SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-163006
Filing Date
2022-05-31
Accepted
2022-05-31 07:07:56
Documents
14
Period of Report
2022-05-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d334309d8k.htm   iXBRL 8-K 25013
2 EX-99.1 d334309dex991.htm EX-99.1 13424
6 GRAPHIC g334309g0531071213485.jpg GRAPHIC 3627
  Complete submission text file 0001193125-22-163006.txt   170563

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tcrx-20220531.xsd EX-101.SCH 2851
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcrx-20220531_lab.xml EX-101.LAB 17979
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcrx-20220531_pre.xml EX-101.PRE 11255
8 EXTRACTED XBRL INSTANCE DOCUMENT d334309d8k_htm.xml XML 3351
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Filer) CIK: 0001783328 (see all company filings)

IRS No.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40603 | Film No.: 22980421
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences